Should You Combine Telmisartan And Nebivolol For Hypertension?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Already a member? Sign In

Timeline

00:00

A 49-year-old man asks about changing his hypertension treatment, and Dr. O’Connor compares lisinopril with telmisartan while explaining why lower doses of complementary blood-pressure medications may work better than maximizing one drug.

02:00

Dr. O’Connor emphasizes checking blood pressure directly, seeking another qualified clinician when necessary, and recognizing that diastolic readings in the mid-80s can already represent stage 1 hypertension.

Video Summary

A 49-year-old man asks about changing blood-pressure treatment after disagreement with his telemedicine provider. Dr. O’Connor compares lisinopril with telmisartan and explains why combining low doses of medications from different antihypertensive classes may provide better blood-pressure control than continually maximizing one medication.

The discussion focuses on telmisartan as an angiotensin receptor blocker and nebivolol as a complementary medication that may be used synergistically at lower doses. Dr. O’Connor encourages the member to discuss evidence-based combination therapy with his treating clinician rather than accepting persistent hypertension or remaining on a regimen that is not working well.

He also emphasizes monitoring blood pressure directly and notes that diastolic readings in the mid-80s can already meet criteria for stage 1 hypertension. The broader message is that uncontrolled blood pressure deserves active treatment and follow-up rather than waiting for it to become more severe.

Drug Callouts

Lisinopril

Lisinopril is the member’s current blood-pressure medication and is discussed as an ACE inhibitor. Dr. O’Connor compares it with an angiotensin receptor blocker and questions relying on one medication when lower-dose combination therapy may provide better control.

Telmisartan

Telmisartan is discussed as an angiotensin receptor blocker the member would prefer to use. Dr. O’Connor supports discussing it with the treating clinician as part of a lower-dose combination strategy for controlling hypertension.

Nebivolol

Nebivolol is discussed alongside telmisartan as a second antihypertensive medication that may provide complementary blood-pressure control when used at a lower dose rather than maximizing a single medication.

Condition Callouts

Hypertension

Persistent hypertension is the central condition discussed, with Dr. O’Connor emphasizing active treatment and direct blood-pressure monitoring. For men using testosterone, controlling blood pressure is especially important because hypertension contributes to long-term cardiovascular and kidney risk within the ABCDs™ framework.

Key Takeaways

Lower doses of complementary antihypertensive medications may provide better blood-pressure control than continually increasing a single drug.
Telmisartan and lisinopril act through related blood-pressure pathways but belong to different medication classes.
Dr. O’Connor discusses combining telmisartan with nebivolol as an evidence-based strategy worth reviewing with the treating clinician.
Persistent hypertension should prompt medication reassessment rather than remaining indefinitely on a regimen that is not providing adequate control.
Persistent hypertension should prompt medication reassessment rather than remaining indefinitely on a regimen that is not providing adequate control.